Even though it is overexpressed by many different leukemias and lymphomas, there is little evidence for FCRL1 as a high-frequency target of recurrent mutation or genetic alteration in the catalogue of somatic mutations in cancer (COSMIC) database or other genomic analyses of lymphomas (25, 27, 123, 124). The gene discussed is FCRL1; the disease is leukemia.